Green Cross Medical Science Corporation (KOSDAQ:142280)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,895.00
-25.00 (-0.64%)
At close: Apr 28, 2026
1.83%
Market Cap 84.68B
Revenue (ttm) 108.41B
Net Income (ttm) 3.67B
Shares Out 21.74M
EPS (ttm) 146.00
PE Ratio 26.68
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 94,870
Average Volume 262,065
Open 3,930.00
Previous Close 3,920.00
Day's Range 3,880.00 - 3,950.00
52-Week Range 3,200.00 - 5,090.00
Beta 0.49
RSI 54.93
Earnings Date Apr 13, 2026

About KOSDAQ:142280

Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin-Si, South Korea. [Read more]

Industry In Vitro and In Vivo Diagnostic Substances
Founded 1972
Employees 122
Stock Exchange KOSDAQ
Ticker Symbol 142280
Full Company Profile

Financial Performance

In 2025, KOSDAQ:142280's revenue was 108.41 billion, an increase of 4.39% compared to the previous year's 103.85 billion. Earnings were 3.67 billion, an increase of 2.38%.

Financial Statements

News

There is no news available yet.